首頁 > 市場調查報告書 > 製藥

生物製劑分子標靶治療學

北美抗體發現市場預測至 2030 年 - 區域分析 - 按抗體類型、性質、服務和最終用戶

市場調查報告書

商品編碼

1592592

北美抗體發現市場預測至 2030 年 - 區域分析 - 按抗體類型、性質、服務和最終用戶

North America Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日期: 2024年09月16日 | 出版商:

The Insight Partners | 英文 94 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美抗體發現市值為129823757萬美元，預計到2030年將達到220169241萬美元；預計2022年至2030年複合年成長率為6.8%。

增加研發投資推動北美抗體發現市場

抗體（包括單株和多株）在學術、研究和製藥機構和組織中得到應用，其中它們用於與藥物和生物標記開發以及其他治療和臨床診斷產品開發相關的多種研發活動。中小企業每年都專注於增加研發投入。 2020年4月，美國聯邦政府根據《冠狀病毒援助、救濟和經濟安全（CARES）法案》向生物醫學高級研究與開發局（BARDA）撥款35億美元，為製造、生產和採購提供財政支持疫苗、診斷、治療和小分子活性藥物成分(API) 等。此外，製藥公司 Bio-Rad 提供 10,000 種抗體以及抗原、試劑和緩衝液，用於開發體外診斷測試。因此，製藥公司增加對抗體發現相關研發活動的投資，為各種疾病開發更好的治療方案，推動抗體發現市場的成長。

北美抗體發現市場概況

北美抗體發現市場分為美國、加拿大和墨西哥。該地區的市場成長取決於癌症盛行率的增加、抗體研究產業的強勁發展以及研發領域的技術進步。根據美國癌症協會的數據，2020 年美國新診斷出約 180 萬癌症病例，約 606,520 例與癌症相關的死亡。資金的激增進一步促進了新技術的開發、跨國家和組織的資源和專業知識的匯集，以及對現有抗體治療方法的研究工作。這使得人們更了解免疫系統，並開發出有效的、有針對性的抗體。此外，增加的資金使科學家能夠進行大規模臨床試驗，這些試驗是評估特定抗體有效性所必需的。

北美抗體發現市場收入及 2030 年預測（十億美元）

北美抗體發現市場細分

北美抗體發現市場按抗體類型、性質、服務、最終用戶和國家分類。

根據抗體類型，北美抗體發現市場分為單株抗體、多株抗體等。 2022 年，單株抗體領域佔據北美最大的抗體發現市場。

就性質而言，北美抗體發現市場分為人類和人源化、嵌合和鼠類。 2022 年，人類和人源化細分市場佔據北美最大的抗體發現市場。

依服務分類，北美抗體發現市場分為噬菌體展示、雜交瘤、基因改造動物、單細胞和酵母展示。 2022 年，噬菌體展示領域佔據北美最大的抗體發現市場。

根據最終用戶，北美抗體發現市場分為製藥和生物技術公司、研究實驗室等。 2022 年，製藥和生物技術公司領域佔據北美最大的抗體發現市場。

根據國家/地區，北美抗體發現市場分為美國、加拿大和墨西哥。 2022 年，美國在北美抗體發現市場佔有率中佔據主導地位。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Bruker Cellular Analysis Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、NanoCellect Biomedical Inc 和 Biocytogen Pharmaceuticals 北京有限公司是其中一些領先公司在北美有限公司發現市場運作。

Antibodies, including monoclonal and polyclonal, find applications in academic, research, and pharmaceutical institutes and organizations, wherein they are used in several R&D activities related to drug and biomarker development, and other therapeutic and clinical diagnostics product development. Small and medium-sized companies focus on raising their R&D investments every year. In April 2020, the US federal government assigned US$ 3.5 billion to the Biomedical Advanced Research and Development Authority (BARDA) under its Coronavirus Aid, Relief, and Economic Security (CARES) Act to provide financial support for the manufacturing, production, and procurement of vaccines, diagnostics, therapeutics, and small molecule active pharmaceutical ingredients (APIs), among others. Further, Bio-Rad, a pharmaceutical company, provides 10,000 antibodies, along with antigens, reagents, and buffers, to develop in vitro diagnostic tests. Therefore, the increasing investments by pharmaceutical companies in research and development activities related to antibody discovery to develop better treatment options for various diseases propels the antibody discovery market growth.

North America Antibody Discovery Market Overview

The North America antibody discovery market is segmented into the US, Canada, and Mexico. Market growth in the region is determined by an increase in the prevalence of cancer, the strong presence of the antibody research industry, and technological advancements in the R&D sector. According to the American Cancer Society, ~1.8 million new cancer cases were diagnosed and ~606,520 deaths related to cancer were recorded in the US in 2020. This bolsters the need for therapeutic antibodies, thereby fueling the antibody discovery market growth. An upsurge in funding further enables the development of new technologies, pooling of resources and expertise across countries and organizations, and conducting research work into existing antibody treatments. This has led to a better understanding of the immune system, and the development of effective and targeted antibodies. Additionally, the increased funding allows scientists to conduct large-scale clinical trials that are mandatory to evaluate the effectiveness of a particular antibody.

North America Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

North America Antibody Discovery Market Segmentation

The North America antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the North America antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest North America antibody discovery market share in 2022.

In terms of nature, the North America antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest North America antibody discovery market share in 2022.

By services, the North America antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest North America antibody discovery market share in 2022.

Based on end user, the North America antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest North America antibody discovery market share in 2022.

Based on country, the North America antibody discovery market is categorized into the US, Canada, and Mexico. The US dominated the North America antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Bruker Cellular Analysis Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, NanoCellect Biomedical Inc, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the North America antibody discovery market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Investments in Research & Development
- 4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
- 4.2.1 High Cost of Production
4.3 Market Opportunities
- 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
- 4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - North America Market Analysis

5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. North America Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview
6.2 Monoclonal Antibodies
- 6.2.1 Overview
- 6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
- 6.3.1 Overview
- 6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Antibody Discovery Market Analysis - by Nature

7.1 Overview
7.2 Human and Humanized
- 7.2.1 Overview
- 7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Antibody Discovery Market Analysis - by Services

8.1 Overview
8.2 Phage Display
- 8.2.1 Overview
- 8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
- 8.3.1 Overview
- 8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
- 8.4.1 Overview
- 8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
- 8.5.1 Overview
- 8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
- 8.6.1 Overview
- 8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Antibody Discovery Market Analysis - by End User

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Antibody Discovery Market - Country Analysis

10.1 North America Market Overview
- 10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 US
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.2 Canada
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.3 Mexico
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Creative Biolabs Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Evotec SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bruker Cellular Analysis Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioDuro LLC
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Sartorius AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Aragen Life Sciences Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Twist Bioscience Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 NanoCellect Biomedical Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 17. Glossary of Terms, Antibody Discovery Market

List Of Figures

Figure 1. North America Antibody Discovery Market Segmentation, by Country
Figure 2. North America Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. North America Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Growth Strategies in the Antibody Discovery Market